1-3 of 3
Naofumi Takemoto
Close
Sort by
Journal Articles

Combination Therapy of Humanized Chimeric-Anti-Human VLA4 Monoclonal Antibodies and Anti-Cancer Drugs for AML.

Takuya Matsunaga, MD, Kazunori Kato, PhD, Maki Tanaka, MD, Yukari Masuta, PhD, Kageaki Kuribayashi, MD, Naofumi Takemoto, MD, Ikuta Tanaka, MD, Akihito Fujimi, MD, Takehide Akiyama, MD, Hirofumi Hamada, MD, Yoshiro Niitsu, MD
Journal: Blood
Blood (2004) 104 (11): 4518.
https://doi.org/10.1182/blood.V104.11.4518.4518
Published: 2004
Journal Articles

Ex Vivo Production of Transfusable Red Blood Cells at Large Scale from Cord Blood CD34+ Cells Using a Coculture System with Human Telomerase Catalytic Subunit (hTERT)-Transfected Human Stromal Cells at Early Phase and with Acitivated Macrophage from Cord Blood CD34+ Cells at Late Phase.

Akihito Fujimi, MD, Takuya Matsunaga, MD, Masayoshi Kobune, MD, Yutaka Kawano, MD, Ikuta Tanaka, MD, Naofumi Takemoto, MD, Takehide Akiyama, MD, Hirofumi Hamada, MD, Yoshiro Niitsu, MD
Journal: Blood
Blood (2004) 104 (11): 2701.
https://doi.org/10.1182/blood.V104.11.2701.2701
Published: 2004
Journal Articles

Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603

Yue Lu, Sumio Sakamaki, Hiroyuki Kuroda, Toshiro Kusakabe, Yuichi Konuma, Takehide Akiyama, Akihito Fujimi, Naofumi Takemoto, Kyokusen Nishiie, Takuya Matsunaga, Yasuo Hirayama, Junji Kato, Shinichiro Kon, Katsuhisa Kogawa, Yoshiro Niitsu
Journal: Blood
Blood (2001) 97 (4): 1123–1130.
https://doi.org/10.1182/blood.V97.4.1123
Published: 2001